{
  "timestamp": "20250103_010714",
  "model": "gpt-4-turbo",
  "interaction_type": "direct_answer",
  "question_id": "4a02a891",
  "question_text": "Which of the following does not cause Insulin release-",
  "messages": [
    {
      "role": "system",
      "content": "You are a medical expert making decisions based on medical knowledge."
    },
    {
      "role": "user",
      "content": "You are a medical expert specializing in the field of Pharmacology.Please help answer this multiple choice question:\n\nQuestion: Which of the following does not cause Insulin release-\n\nOptions:\nopa. Rosiglitazone\nopb. Nateglinide\nopc. Glimipiride\nopd. Tobutamide\n\n        ### Output Format\n        Provide your response in valid JSON format:\n        {   \n            \"final_analysis\": \"Your concise analysis following the above structure\",\n            \"answer\": \"Option key from the available options (only key,like opa)\",\n            \"confidence\": Score between 0-100 based on alignment with established medical facts\n        }\n        "
    }
  ],
  "response": "{\n    \"final_analysis\": \"Rosiglitazone is a thiazolidinedione, which works primarily by increasing insulin sensitivity rather than stimulating pancreatic insulin secretion. Nateglinide, Glimepiride, and Tolbutamide are all sulfonylureas or similar drugs that directly stimulate the pancreas to release insulin.\",\n    \"answer\": \"opa\",\n    \"confidence\": 95\n}",
  "metadata": {
    "topic": "Pharmacology",
    "is_multi_choice": true,
    "has_reasoning_chain": false,
    "has_enhanced_info": false,
    "model_config": "gpt-4-turbo",
    "temperature": 0.0
  }
}